21 Stocks Moving in Wednesday's Pre-Market Session

Gainers

  • GBS Inc. GBS rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-19 diagnostic with Harvard's Wyss Institute.
  • Field Trip Health Ltd. FTRP shares rose 30% to $6.25 in pre-market trading. HC Wainwright & Co. initiated coverage on Field Trip Health with a Buy rating and announced a price target of $20.
  • Focus Universal Inc. FCUV rose 25.1% to $6.38 in pre-market trading after dropping 15% on Tuesday. Focus Universal priced 2 million shares at $5 per share to raise $10 million for its initial public offering on the Nasdaq.
  • Baudax Bio, Inc. BXRX shares rose 17.5% to $0.74 in pre-market trading. Baudax Bio’s CFO Richard Casten recently reported the purchase of 50,000 shares at an average price of $0.51 per share in a Form 4 filing.
  • Anaplan, Inc. PLAN rose 16.8% to $70.08 in pre-market trading after the company reported better-than-expected Q2 results and issued Q3 sales guidance above estimates. The company also raised FY22 sales guidance.
  • China Online Education Group COE shares rose 9.8% to $3.46 in pre-market trading after surging over 13% on Tuesday.
  • LAIX Inc. LAIX rose 8.5% to $1.28 in pre-market trading after jumping over 11% on Tuesday. LAIX recently posted a Q2 loss of $0.04 per share.
  • Caleres, Inc. CAL shares rose 8.5% to $26.71 in pre-market trading after the company reported upbeat results for its second quarter. The company said it sees FY21 adjusted earnings of $3.25 to $3.50 per share.
  • Ambarella, Inc. AMBA rose 8.1% to $112.00 in pre-market trading after the company reported better-than-expected Q2 results and issued Q3 sales guidance above estimates.
  • Atai Life Sciences N.V. ATAI rose 8.1% to $17.72 in pre-market trading. The company, earlier during the month, reported worse-than-expected Q2 financial results.
  • RenovoRx, Inc. RNXT rose 7.5% to $10.74 in pre-market trading after dipping around 38% on Tuesday. The company was recently granted FDA clearance for 'Catheter, Intravascular Occluding, Temporary.'
  • Skillz Inc. SKLZ shares rose 6.8% to $12.58 in pre-market trading after gaining around 11% on Tuesday.
  • The OLB Group, Inc. OLB rose 5.6% to $4.52 in pre-market trading after climbing over 11% on Tuesday.
  • Dynavax Technologies Corporation DVAX rose 5.3% to $20.50 in pre-market trading. HC Wainwright, on Tuesday, maintained a Buy rating on the stock and raised its price target from $20 to $23.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Valneva SE VALN shares fell 12.2% to $46.55 in pre-market trading. Valneva recently commenced rolling submission for its COVID-19 vaccine candidate with the Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K.
  • Lucid Group, Inc. LCID fell 9.1% to $18.15 in pre-market trading. Lucid Group recently said it will produce its limited-run Lucid Air Dream Edition in two distinct versions – the Dream Edition Performance and the Dream Edition Range.
  • Elys Game Technology, Corp. ELYS shares fell 7.9% to $6.10 in pre-market trading. Elys Game Technology shares jumped 43% on Tuesday after it was reported the company received its Washington, DC sports betting license.
  • Unico American Corporation UNAM shares fell 7.9% to $3.82 in pre-market trading after jumping 59% on Tuesday.
  • Mesoblast Limited MESO fell 6.6% to $6.10 in pre-market trading. Mesoblast shares fell over 10% on Tuesday after the company reported Q4 earnings results.
  • So-Young International Inc. SY fell 6% to $5.50 in pre-market trading. So-Young is expected to report Q2 financial results on September 10, 2021.
  • NIO Inc. NIO fell 4.2% to $37.65 in pre-market trading. NIO reported Wednesday a month-over-month drop in August's vehicle deliveries and trimmed its third-quarter deliveries outlook. The company attributed supply chain disruptions for the soft August numbers and the tempered third-quarter forecast.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!